Apollo Hospitals has announced robust financial results for the fourth quarter of FY26, showcasing an 18% increase in revenue to Rs 6,605 crore compared to Rs 5,592 crore in the same period last year. The company's profit after tax (PAT) rose by 5.4% sequentially to Rs 529 crore, up from Rs 502 crore in the previous quarter. This growth was supported by a 2% increase in topline revenue from Rs 6,477 crore in the October-December quarter of FY26. The board has recommended a final dividend of Rs 10 per equity share for FY26, with the record date set for August 14, 2026.
The company's Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) for the quarter reached Rs 1,011 crore, marking a 31% year-on-year growth, reflecting the strong operational momentum and resilient demand across its healthcare services. The healthcare services segment alone reported a 16% YoY revenue growth to Rs 3,268 crore, with EBITDA margins at 23.9%. Apollo Health and Lifestyle saw a 24% YoY increase in revenue to Rs 489 crore, while Apollo HealthCo's revenue grew by 20% YoY to Rs 2,848 crore.
For the full fiscal year, Apollo Hospitals reported a consolidated revenue increase of 16% YoY to Rs 25,229 crore, driven by robust growth across its healthcare and digital platforms. Despite significant investments in Apollo 24/7, which incurred costs of Rs 467 crore, the company's EBITDA rose to Rs 3,769 crore from Rs 3,022 crore in FY25. The PAT for FY26 surged to Rs 1,942 crore, with diluted earnings per share (EPS) at Rs 134.95. Apollo 24/7 recorded a gross merchandise value (GMV) of Rs 2,037 crore, highlighting the continued traction in its digital healthcare ecosystem. These results underscore Apollo Hospitals' strategic focus on expanding its healthcare and digital services, positioning it well for future growth.
